What is the current Fibrin Medical Adhesive market size?

The Fibrin Medical Adhesive market size reached USD 1.2 billion in 2023, driven by rising surgical volumes and adoption of minimally invasive procedures.

What is the expected growth rate of the market?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, reaching USD 2.0 billion by the end of the forecast period.

What are the key drivers of market growth?

Key drivers include increasing surgical complexities, rising demand for biocompatible adhesives, and expansion of regenerative medicine applications.

What challenges does the market face?

High production costs, stringent regulatory compliance, and competition from alternative hemostatic products hinder market growth.

Which regions are leading the market?

North America dominates the market due to advanced healthcare infrastructure, while Asia-Pacific shows fastest growth due to rising medical tourism.

Who are the top companies in the market?

Leading players include Baxter International, B. Braun Melsungen, and Medtronic, focusing on R&D and strategic partnerships to maintain market share.

What future opportunities exist in the market?

Emerging opportunities lie in personalized medicine applications, expansion into veterinary care, and adoption in emerging economies.

How is technology impacting the market?

Advancements in bioengineering and 3D printing are enabling development of tailored fibrin-based solutions with improved adhesive properties.

What is the regulatory landscape like?

Regulatory frameworks by FDA and EMA emphasize safety, efficacy, and batch consistency, creating barriers but ensuring product quality across global markets.

Fibrin Medical Adhesive Market: Opportunity by 2034 | In-Depth Report

Fibrin Medical Adhesive by Application (Dental, Internal Surgery, External Surgery, Medical Device and Equipment, Others), by Types (Water-based, Solvent-based, Solids and Hot Melt-based), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Fibrin Medical Adhesive Market Size | CAGR 15.2 Forecast 2033

Fibrin Medical Adhesive Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Fibrin Medical Adhesive Market Overview

The Fibrin Medical Adhesive market represents a critical segment within the surgical biomaterials industry, offering solutions for tissue sealing, hemostasis, and wound closure. These adhesives, derived from plasma proteins or synthetic alternatives, are increasingly adopted in minimally invasive procedures and trauma care due to their biocompatibility and rapid bonding properties. The Fibrin Medical Adhesive market size is estimated at USD 1.8 billion in 2025, reflecting robust industry expansion driven by evolving clinical practices and a growing emphasis on reducing surgical recovery times. This market forecast underscores a CAGR of 6.8% through 2033, with key macro drivers including the rise in chronic wound management, advancements in biodegradable adhesive technologies, and regulatory tailwinds supporting safer alternatives to traditional sutures.

Loading chart…

The Fibrin Medical Adhesive market growth outlook is shaped by technological innovation in adhesive formulations and regulatory harmonization across key regions. North America remains the largest market due to its established adoption of advanced surgical adhesives, while Asia-Pacific is the fastest-growing region, fueled by expanding healthcare infrastructure and rising demand for cost-effective wound care solutions. The shift toward synthetic adhesives (highlighted in the chart) reflects industry trends prioritizing consistency and reduced disease transmission risks. Competitive intensity is rising as biotech firms invest in next-generation products, positioning the market for sustained expansion amid evolving clinical standards.

Report Overview

Report Attribute	Details
Market size value in 2025	350.00 million
Revenue forecast in 2033	1.09 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ethicon; Henkel AG and Co. KGaA; 3M; Baxter International Inc.; Nitto Denko Corporation; B. Braun Melsungen AG; Scapa Group PLC; Adhezion Biomedical, LLC; Chemence; Covidien; Dentsply Sirona; H.B. Fuller Company; Permabond LLC; Master Bond Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Technological innovation in biocompatible adhesives is accelerating adoption, with fibrin-based products offering superior hemostatic properties and reduced scarring compared to traditional sutures. These advancements are particularly driving the Fibrin Medical Adhesive market size in complex surgical procedures such as cardiovascular and orthopedic applications.

Rising demand for minimally invasive surgeries (MIS) is amplifying the need for precision adhesives. Fibrin adhesives enable faster recovery times and reduced hospital stays, aligning with global cost-containment strategies in healthcare systems.

Restraints2 items

High production costs associated with human plasma-derived fibrinogen limit accessibility in low- and middle-income countries, where budget constraints often prioritize cheaper, synthetic alternatives.

Stringent regulatory requirements across regions like Europe and Asia-Pacific delay product approvals, creating barriers for new entrants and slowing market expansion.

Opportunities2 items

Expansion into emerging markets (e.g., India, Brazil) presents untapped potential, driven by improving healthcare infrastructure and rising surgical volumes in urban centers.

Collaborations with pharmaceutical giants to develop hybrid adhesives combining fibrin with synthetic polymers could unlock new growth forecast projections by enhancing durability and cost-efficiency.

Challenges2 items

Supply chain vulnerabilities tied to plasma donations and purification processes risk shortages, particularly during global health crises like the COVID-19 pandemic.

Intense competition from tissue sealants and cyanoacrylate adhesives threatens market share, necessitating continuous R&D investment to highlight fibrin’s superior biocompatibility.

Market Segmentation

Loading chart…

Fibrin Medical Adhesive segmentation by application reveals distinct clinical utility. Surgical applications dominate, accounting for ~55% of the market, driven by its role in wound closure during procedures like cardiothoracic and orthopedic surgeries. Trauma care contributes ~25%, reflecting its use in emergency settings for sealing lacerations and fractures. Dental applications represent ~15%, leveraging adhesive properties in procedures such as periodontal surgery. The remaining 5% includes niche uses in ophthalmology and veterinary medicine. This market taxonomy highlights surgical demand as the primary growth engine, with trauma and dental segments showing steady expansion due to rising accident rates and dental healthcare adoption.

Fibrin Medical Adhesive market taxonomy by type is bifurcated into human-derived and synthetic categories. Human-derived adhesives, comprising ~60% of the market, rely on pooling human plasma and remain the standard due to biocompatibility and regulatory acceptance. Synthetic alternatives, capturing ~40%, are gaining traction via innovations in recombinant technology and reduced risk of disease transmission. Cost efficiency and scalability of synthetic variants are accelerating their adoption in emerging markets. This Fibrin Medical Adhesive segmentation underscores a competitive equilibrium, with human-derived products maintaining dominance while synthetic options drive incremental growth through technological advancements and cost advantages.

Fibrin Medical Adhesive Segmentation Breakdown10 items

Application

Dental

Internal Surgery

External Surgery

Medical Device and Equipment

Others

Types

Water-based

Solvent-based

Solids and Hot Melt-based

Regional Insights

Loading chart…

The Fibrin Medical Adhesive market growth is led by North America, which holds the largest regional share at 32%, driven by advanced healthcare infrastructure, high surgical adoption rates, and robust R&D investments. The region benefits from a mature ecosystem, stringent regulatory frameworks ensuring product quality, and aging demographics fueling demand for orthopedic and cardiovascular procedures. Europe follows closely at 24%, supported by favorable reimbursement policies, strong policy backing for medical innovation, and a well-established healthcare network. Germany and France remain key markets due to their early adoption of minimally invasive surgical techniques.

The Asia Pacific region emerges as the fastest-growing market, projected to expand at a CAGR of 9.8% through 2030, with a current share of 21%. Rapid urbanization, rising healthcare investments, and growing awareness of advanced wound care solutions in China, India, and Southeast Asia are critical drivers. However, infrastructure disparities and affordability challenges persist. Latin America (14%) and the Middle East & Africa (9%) face slower growth due to underdeveloped healthcare ecosystems and limited policy support, though niche markets in Brazil and Saudi Arabia show incremental progress through public-private partnerships.

Regional forecast analysis highlights North America as the dominant player, while Asia Pacific offers transformative growth potential. Strategic investments in Fibrin Medical Adhesive market expansion should prioritize APAC’s untapped surgical demand and Europe’s regulatory alignment, while addressing Latin America and MEA’s infrastructural gaps to unlock long-term value.

Competitive Landscape

The Fibrin Medical Adhesive market is moderately consolidated, with a mix of global players and regional manufacturers competing on pricing, regulatory approvals, and product differentiation. Key players such as Ethicon and Baxter International Inc. leverage extensive regulatory certifications and diversified product portfolios to maintain market presence, while smaller firms like Adhezion Biomedical, LLC focus on niche applications. Competitive levers include rapid innovation in bioadhesive formulations, strategic partnerships for distribution, and cost optimization through localized manufacturing. The Fibrin Medical Adhesive key players face pressure to balance R&D investments with pricing constraints in price-sensitive end markets.

Strategic priorities among competitors include geographic expansion, M&A activity to consolidate regional footprints, and collaboration with OEMs for healthcare integration. Differentiation arises from proprietary tissue adhesion technologies, customization for surgical sub-specialties, and channel strength in hospital procurement networks. A critical challenge is rising compliance costs due to evolving FDA and EMA regulations, which narrow profit margins and necessitate continuous quality assurance investments. Companies are also addressing supply chain fragility by diversifying raw material sourcing and adopting localized production hubs.

Ethicon: product innovation pipeline for advanced surgical hemostasis

Henkel AG: OEM tie-ups to expand medical device integration

3M: R&D focus on broadening application scope in wound care

Baxter International Inc.: localization strategy for emerging markets

Nitto Denko Corporation: vertical integration for cost control

B. Braun Melsungen AG: premium pricing for high-performance surgical adhesives

Key Fibrin Medical Adhesive Companies14 items

Ethicon

Henkel AG and Co. KGaA

Baxter International Inc.

Nitto Denko Corporation

B. Braun Melsungen AG

Scapa Group PLC

Adhezion Biomedical, LLC

Chemence

Covidien

Dentsply Sirona

H.B. Fuller Company

Permabond LLC

Master Bond Inc.

Market Ecosystem

The Fibrin Medical Adhesive ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream distributors and end users. Value is generated through the production of fibrinogen and thrombin derivatives, formulation of adhesive products, and their application in surgical and wound care settings. The ecosystem is shaped by medical device regulations, clinical validation, and supply chain dynamics.

Raw material suppliers — Provide fibrinogen, thrombin, and buffers for adhesive formulation

Technology providers — License proprietary methods for adhesive stabilization and delivery

OEM manufacturers — Produce medical adhesive kits through precision blending and packaging

Distributors — Handle regional logistics and regulatory compliance for healthcare facilities

Hospital procurement departments — Evaluate and adopt products based on clinical efficacy and cost

Regulatory bodies — Oversee product approvals and post-market safety monitoring

After-sales service providers — Offer training and technical support for adhesive application systems

Control points reside in regulatory approvals and raw material availability, creating dependency risks for manufacturers. Switching costs for end users are influenced by device compatibility with existing surgical workflows and training programs. Partnerships between OEMs and distributors are critical for market access, while interoperability with hospital sterilization protocols affects adoption rates. Regional variations in reimbursement policies further segment the ecosystem.

Recent Industry Insights

The Fibrin Medical Adhesive industry trends over the past 18 months reflect accelerated innovation driven by surgical demand and regulatory shifts. Strategic partnerships, such as Baxter’s collaboration with a biotech firm to enhance product distribution in Asia-Pacific, have expanded market access. Mergers and acquisitions, including Johnson & Johnson’s acquisition of a niche fibrin sealant developer, underscore consolidation in the sector. Technological advancements include the launch of next-generation bioabsorbable adhesives by CryoLife, offering faster tissue integration. Regulatory changes, notably the FDA’s updated guidelines on hemostatic agents, have prompted manufacturers to prioritize safety and biocompatibility. Meanwhile, the shift toward minimally invasive surgeries has increased demand for precision-adhesive solutions, pushing companies to invest in R&D. Notably, startups like Fibrinogenics secured $50M in Series B funding to scale production, while industry players eye expansion in emerging markets, positioning the sector for sustained growth in 2024–2025.

Analyst Overview

The Fibrin Medical Adhesive market outlook remains robust, driven by rising demand for advanced wound closure solutions and expanding applications in surgical and dental procedures. Market attractiveness is high, underpinned by growth in minimally invasive surgeries and increasing adoption in emerging economies. Competitive intensity is moderate, with established players focusing on product differentiation and strategic partnerships to strengthen market share. The long-term outlook is optimistic, supported by aging demographics and advancements in biocompatible materials, though regulatory variations may pose entry barriers. Innovation landscape highlights R&D efforts in bioengineered adhesives and application-specific formulations to enhance performance and reduce complications. Despite strong demand, demand–supply balance faces periodic strain due to raw material constraints and production complexities. Key risk factors include stringent regulatory compliance, fluctuating healthcare budgets, and the potential for generic or synthetic alternatives to disrupt market dynamics. Decision-makers must prioritize agility to navigate these challenges while capitalizing on high-growth opportunities.

12 items

1. Executive Summary

2. Fibrin Medical Adhesive Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Fibrin Medical Adhesive Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Fibrin Medical Adhesive Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Fibrin Medical Adhesive Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Fibrin Medical Adhesive Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Fibrin Medical Adhesive Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Fibrin Medical Adhesive Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Fibrin Medical Adhesive Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Fibrin Medical Adhesive Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Fibrin Medical Adhesive Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Fibrin Medical Adhesive Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Fibrin Medical Adhesive Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Fibrin Medical Adhesive Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Fibrin Medical Adhesive Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Fibrin Medical Adhesive Market Competition by Key Manufacturers

9.1. Global Fibrin Medical Adhesive Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Fibrin Medical Adhesive: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Ethicon

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Henkel AG and Co. KGaA

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. 3M

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Baxter International Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Nitto Denko Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. B. Braun Melsungen AG

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Scapa Group PLC

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Adhezion Biomedical, LLC

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Chemence

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Covidien

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Dentsply Sirona

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. H.B. Fuller Company

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Permabond LLC

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Master Bond Inc.

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Fibrin Medical Adhesive Market

Figure 4: Global Fibrin Medical Adhesive Market: Drivers

Figure 5: Global Fibrin Medical Adhesive Market: Challenges

Figure 6: Global Fibrin Medical Adhesive Market: Trends

Figure 7: Global Fibrin Medical Adhesive Market: Opportunity

Figure 8: Global Fibrin Medical Adhesive Market: Restraint

Figure 9: Global Fibrin Medical Adhesive Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Fibrin Medical Adhesive Market Value (USD Million) By Region

Figure 19: Global Fibrin Medical Adhesive Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Fibrin Medical Adhesive Market Value (USD Million) By Region

Figure 27: Global Fibrin Medical Adhesive Market Share (%) By: Regions (2032)

Figure 28: Global Fibrin Medical Adhesive Market Volume (K) By Region

Figure 29: Global Fibrin Medical Adhesive Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Fibrin Medical Adhesive Market Value (USD Million) By Region

Figure 37: Global Fibrin Medical Adhesive Market Share (%) By: Regions (2032)

Figure 38: Global Fibrin Medical Adhesive Market Volume (K) By Region

Figure 39: Global Fibrin Medical Adhesive Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Fibrin Medical Adhesive Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Fibrin Medical Adhesive Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Fibrin Medical Adhesive Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Fibrin Medical Adhesive Market Value (USD Million) By Region

Table 14: Global Fibrin Medical Adhesive Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Fibrin Medical Adhesive Market Volume (K) By Region

Table 31: Global Fibrin Medical Adhesive Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Fibrin Medical Adhesive Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Fibrin Medical Adhesive Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Fibrin Medical Adhesive Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Ethicon Basic Information And Sales Area

Table 52: Ethicon. Products Portfolio

Table 53: Henkel AG and Co. KGaA Basic Information And Sales Area

Table 54: Henkel AG and Co. KGaA. Products Portfolio

Table 55: 3M Basic Information And Sales Area

Table 56: 3M. Products Portfolio

Table 57: Baxter International Inc. Basic Information And Sales Area

Table 58: Baxter International Inc.. Products Portfolio

Table 59: Nitto Denko Corporation Basic Information And Sales Area

Table 60: Nitto Denko Corporation. Products Portfolio

Table 61: B. Braun Melsungen AG Basic Information And Sales Area

Table 62: B. Braun Melsungen AG. Products Portfolio

Table 63: Scapa Group PLC Basic Information And Sales Area

Table 64: Scapa Group PLC. Products Portfolio

Table 65: Adhezion Biomedical, LLC Basic Information And Sales Area

Table 66: Adhezion Biomedical, LLC. Products Portfolio

Table 67: Chemence Basic Information And Sales Area

Table 68: Chemence. Products Portfolio

Table 69: Covidien Basic Information And Sales Area

Table 70: Covidien. Products Portfolio

Table 71: Dentsply Sirona Basic Information And Sales Area

Table 72: Dentsply Sirona. Products Portfolio

Table 73: H.B. Fuller Company Basic Information And Sales Area

Table 74: H.B. Fuller Company. Products Portfolio

Table 75: Permabond LLC Basic Information And Sales Area

Table 76: Permabond LLC. Products Portfolio

Table 77: Master Bond Inc. Basic Information And Sales Area

Table 78: Master Bond Inc.. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Fibrin Medical Adhesive Market Value (USD Million) By Region

Table 88: Global Fibrin Medical Adhesive Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Fibrin Medical Adhesive Market Volume (K) By Region

Table 105: Global Fibrin Medical Adhesive Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Fibrin Medical Adhesive Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	350.00 million
Revenue forecast in 2033	1.09 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ethicon; Henkel AG and Co. KGaA; 3M; Baxter International Inc.; Nitto Denko Corporation; B. Braun Melsungen AG; Scapa Group PLC; Adhezion Biomedical, LLC; Chemence; Covidien; Dentsply Sirona; H.B. Fuller Company; Permabond LLC; Master Bond Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options